Skip to main content

Table 6 Sensitivity and specificity for colorectal cancer and significant colonic lesion of the prediction models at the thresholds with 90 % (5.6) and 99 % (3.5) sensitivity for colorectal cancer detection in patients referred for colonoscopy from primary and secondary healthcare

From: Development and external validation of a faecal immunochemical test-based prediction model for colorectal cancer detection in symptomatic patients

COLONPREDICT score

Colorectal cancer

Advanced neoplasiaa

Significant colonic lesionb

Primary

Secondary

p c

Primary

Secondary

p c

Primary

Secondary

p c

≥5.6

Sensitivityd

89.0 % (81.6–93.8)

88.9 % (83.9–92.6)

1

70.8 % (64.4–76.5)

64.1 % (59.6–68.4)

0.5

65.3 % (59.3–70.9)

60.2 % (55.9–64.3)

0.1

Specificityd

75.8 % (72.6–78.8)

80.3 % (78.4–82.1)

0.01

80.8 % (77.5–83.7)

83.8 % (81.8–85.6)

1

81.6 % (78.2–84.5)

84.5 % (82.5–86.3)

0.1

≥3.5

Sensitivityd

100 % (96.1–100.0)

99.6 % (97.2–100.0)

1

91.4 % (86.8–94.5)

87.8 % (84.4–90.5)

0.1

88.6 % (84.0–92.0)

86.1 % (82.8–88.9)

0.3

Specificityd

44.1 % (40.6–47.7)

47.1 % (44.8–49.4)

0.1

48.8 % (45.0–52.8)

51.0 % (48.4–53.5)

0.6

50.1 % (46.0–54.1)

52.1 % (49.5–54.6)

0.4

  1. aColorectal cancer, advanced adenoma (≥10 mm, villous histology, high-grade dysplasia
  2. bColorectal cancer, advanced adenoma (≥10 mm, villous histology, high-grade dysplasia), polyposis (>10 polyps of any histology), colitis (any aetiology), polyps ≥10 mm, complicated diverticular disease, colonic ulcer and/or bleeding angiodysplasia
  3. cSignificance of the sensitivity and specificity differences between both cohorts in the Chi-square test. Differences with p < 0.05 are considered statistically significant
  4. dValues are expressed as the percentage and its 95 % confidence interval